MRI results may not be effective at indicating disability for patients with secondary progressive multiple sclerosis (SPMS), new research suggests. Analysis from the phase 3 ASCEND trial of almost 900 ...

This publication was sponsored and written in partnership with Bristol-Myers Squibb. The American Journal of Managed Care ®: What are some specific patient characteristics associated with ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...

Pregnancy was not linked with long-term disability outcomes in women with moderately severe multiple sclerosis (MS), registry data suggested. There was no significant difference in time to 6-month ...

Please provide your email address to receive an email when new articles are posted on . Study examined 41 individuals with RRMS and 20 healthy controls required to wear accelerometer for 1 week.

The results suggest that delaying initiation of disease-modifying therapy (DMT), especially after a poorly recovered relapse, decreases the likelihood of remaining disability free by age 45. Patients ...

Starting high-efficacy monoclonal antibody therapy during childhood reduced long-term disability in pediatric-onset multiple sclerosis (MS), registry data suggested. Among 282 patients with ...

Please provide your email address to receive an email when new articles are posted on . WEST PALM BEACH, Florida — BMI was significantly associated with functional disability in patients with MS, as ...